News

Risk of acute pancreatitis with carbimazole use (MHRA Drug Safety Update)

The MHRA has released a Drug Safety Update about the risk of acute pancreatitis with the use of products containing carbimazole.

 

If acute pancreatitis occurs during treatment with carbimazole, immediately and permanently stop treatment. Re-exposure to carbimazole may result in life-threatening acute pancreatitis with a decreased time to onset.


Further information, including advice for healthcare professionals, is available on the MHRA website.

Loading...

Email newsletter

Want the latest pharmacy news and updates straight to your inbox?

Sign up to our regular newsletter for the latest guidance, news, events and CPD opportunities.

Sign Up